NantHealth, NantKwest and NantOmics Announce Availability of GPS Cancer and Phase I-III QUILT Trials Through the U.S. National Institute of Health's

“The accessibility of QUILT trials through the NIH registry allows us to better inform patients and healthcare providers about immunotherapy based trials now available and enrolling for a variety of cancers,” stated Dr. Patrick Soon-Shiong, CEO of NantHealth.

Read all details here